Public Profile

Roche Diabetes Care, Inc.

Roche Diabetes Care, Inc., a prominent player in the diabetes management industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1896, Roche has established itself as a leader in innovative healthcare solutions, particularly in diabetes care. The company is renowned for its cutting-edge blood glucose monitoring systems, insulin delivery devices, and digital health solutions, which empower patients to manage their diabetes effectively. Roche Diabetes Care's unique approach combines advanced technology with user-friendly design, ensuring that individuals with diabetes can easily monitor their health. With a strong market position, the company has achieved notable milestones, including the development of the Accu-Chek product line, which is widely recognised for its reliability and accuracy. Through continuous innovation and a commitment to improving patient outcomes, Roche Diabetes Care remains at the forefront of diabetes management solutions.

DitchCarbon Score

How does Roche Diabetes Care, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

38

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Roche Diabetes Care, Inc.'s score of 38 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Roche Diabetes Care, Inc.'s reported carbon emissions

Roche Diabetes Care, Inc., headquartered in the US, currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is challenging to assess their climate impact or commitments. However, the company is likely engaged in industry-standard practices aimed at reducing carbon footprints and enhancing sustainability. As the global focus on climate change intensifies, Roche Diabetes Care may be expected to align with broader industry initiatives and commitments to reduce greenhouse gas emissions in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Roche Diabetes Care, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Roche Diabetes Care, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Roche Diabetes Care, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Medtronic MiniMed, Inc.

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Ypsomed

CH
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Diab

SE
Other business services (74)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers